| IORPX | SPAYX | IORPX / SPAYX | |
| Total Expense Ratio | 0.62 | 0.48 | 129% |
| Annual Report Gross Expense Ratio | 0.62 | 0.59 | 105% |
| Fund Existence | 7 years | 11 years | - |
| Gain YTD | 2.119 | 0.545 | 389% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 669M | 139M | 481% |
| Annual Yield % from dividends | 4.64 | 2.41 | 193% |
| Returns for 1 year | 7.24 | 5.04 | 144% |
| Returns for 3 years | 12.06 | 9.89 | 122% |
| Returns for 5 years | 5.52 | 2.94 | 188% |
| Returns for 10 years | N/A | 13.74 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IHE | 90.02 | 1.03 | +1.16% |
| iShares US Pharmaceuticals ETF | |||
| RINF | 32.76 | -0.02 | -0.07% |
| ProShares Inflation Expectations | |||
| UPSG | 17.26 | -0.02 | -0.13% |
| Leverage Shares 2X Long UPS Daily ETF | |||
| CHGX | 33.39 | -0.12 | -0.37% |
| EA SERIES TRUST STANCE SUSTAINABLE BETA ETF | |||
| ITOT | 165.05 | -1.21 | -0.73% |
| iShares Core S&P Total US Stock Mkt ETF | |||